Clinical Trials Directory

Trials / Conditions / Left Ventricular Hypertrophy

Left Ventricular Hypertrophy

79 registered clinical trials studyying Left Ventricular Hypertrophy14 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAI-based Echocardiography for Detection of Cardiac Amyloidosis
NCT07529860
Germans Trias i Pujol HospitalN/A
Not Yet RecruitingLeft Ventricular Hypertrophy in CKD Patients
NCT07380893
Sohag University
RecruitingUS Benchmarking Clinical Study
NCT07215715
eMyosound SAS
RecruitingEvaluation of Left Ventricular Ejection Fraction Using an Accelerated Cardiac Cine-MRI Sequence With Deep Lear
NCT07061821
Centre Hospitalier Universitaire, AmiensN/A
RecruitingAI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy
NCT07263204
Second Affiliated Hospital, School of Medicine, Zhejiang University
RecruitingPoint-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy
NCT05730309
Yale UniversityN/A
UnknownA Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
NCT05903313
Chang Gung Memorial Hospital
UnknownScreening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertr
NCT06169358
Qilu Hospital of Shandong University
RecruitingMineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
NCT05593055
Brigham and Women's HospitalPhase 4
RecruitingSodium Lowering Vascular Effects Trial
NCT05388032
Tulane UniversityN/A
RecruitingEtiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data.
NCT05942729
Hospices Civils de Lyon
UnknownMulti-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults
NCT05719337
First Hospital of China Medical University
CompletedA Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
NCT05646056
Prolaio
CompletedSGLT2 Inhibition in Hemodialysis
NCT05179668
Medical University of ViennaPhase 2
UnknownLeft Ventricular Hypertrophy Among Chronic Kidney Disease Patients in Assiut University Hospital
NCT05002010
Assiut University
UnknownSacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.
NCT04929600
Shanghai Jiao Tong University School of MedicinePhase 4
RecruitingPostnatal Steroids Effects on Cardiac Function in Extremely Preterm
NCT04644094
McGill University Health Centre/Research Institute of the McGill University Health Centre
RecruitingPediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
NCT04752293
Wake Forest University Health Sciences
CompletedEmpagliflozin and Cardiac Remodelling in People Without Diabetes
NCT04461041
Unity Health TorontoPhase 4
CompletedDemographical and Clinical Profile of Patients With Left Ventricular Hypertrophy
NCT04275882
Cardiovascular Academy Society, Turkey
UnknownProtective Monocytes and Macrophages to Limit Decompensation and Heart Damaging
NCT04022330
Assistance Publique - Hôpitaux de ParisN/A
CompletedFGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)
NCT03489993
Wake Forest University Health Sciences
CompletedStudy to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disea
NCT03666351
Hanmi Pharmaceutical Company LimitedPhase 4
RecruitingImaging Histone Deacetylase in the Heart
NCT03549559
Massachusetts General HospitalN/A
CompletedMechanism of Decompensation Evaluation - Aortic Stenosis
NCT03332745
University of Edinburgh
SuspendedAnemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Pati
NCT03193073
Omnia Mohammed HashemN/A
UnknownThe Use of Blood Biochemical Markers for Diagnostics of Heart Muscle Diseases
NCT05726695
University Hospital Ostrava
CompletedEffect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients
NCT03182699
Rainer OberbauerPhase 4
RecruitingDiffusion MRI in Heart Failure
NCT02973633
Massachusetts General HospitalEARLY_Phase 1
CompletedDoes Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?
NCT02956811
University of DundeePhase 4
UnknownMRI Sequence and Imaging Protocol Development
NCT03040947
National Heart Centre Singapore
CompletedAssociation of Mean Platelet Volume and Cardiovascular Disease in Children With End Stage Renal Disease.
NCT03759002
Isfahan University of Medical Sciences
RecruitingResponse of the Myocardium to Hypertrophic Conditions in the Adult Population
NCT02670031
National Heart Centre Singapore
UnknownEffects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study
NCT02493465
Instituto de Urologia e NefrologiaPhase 4
CompletedMetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Diseas
NCT02226510
University of DundeePhase 4
CompletedReNEW Clinic Cohort Study
NCT03816462
Johns Hopkins University
CompletedReduction of Left Ventricular Hypertrophy After Eplerenone Therapy
NCT03186742
Poznan University of Medical SciencesPhase 4
CompletedIn-Centre Nocturnal Hemodialysis (INHD): A Long-Term Follow-Up Study
NCT02684773
Unity Health Toronto
CompletedScreening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography
NCT02221141
Laurence Gabriel
CompletedFrequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose)
NCT03322319
University Hospital Center of MartiniqueN/A
CompletedDoes ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study
NCT01951404
University of DundeePhase 4
CompletedMetabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome
NCT02295176
RottapharmN/A
CompletedFimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG
NCT03219632
Seoul National University Bundang Hospital
CompletedVitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients
NCT01360476
Wayne State UniversityN/A
UnknownSerum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Pati
NCT01382966
RFM Renal Treatment Services
TerminatedThe Effect of Heart Rate on Cardiac Index in Patients With Left Ventricular Hypertrophy
NCT01241838
University of AarhusN/A
TerminatedImpact of Physical Activity on Left Ventricular Mass and Lipid Metabolism
NCT01199211
University of California, San Francisco
CompletedThe Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients
NCT01455974
Capital Medical UniversityN/A
TerminatedEffects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy
NCT01188369
University of AarhusPhase 4
CompletedBelgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy
NCT01198899
University Hospital, Ghent
CompletedEffects Of Volume Control Guided by Body Composition Monitor (BCM) on Blood Pressure and Cardiac Condition in
NCT00974857
Ege UniversityPhase 4
CompletedEvaluation of Regional Myocardial Dynamics at Physical Stress in Essential Hypertension
NCT01442116
Mustafa Kemal UniversityN/A
CompletedAngiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis
NCT00985322
Mario Negri Institute for Pharmacological ResearchPhase 3
UnknownViennese Prevalence Study of Anderson-Fabry Disease
NCT00871611
Medical University of Vienna
CompletedImpact of In-centre Nocturnal Hemodialysis on Ventricular Remodeling and Function in End-stage Renal Disease
NCT00718848
Unity Health Toronto
CompletedThe PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chron
NCT00497146
AbbVie (prior sponsor, Abbott)Phase 3
CompletedDo Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiov
NCT00688480
A. D. StruthersPhase 4
CompletedDallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort
NCT00344903
University of Texas Southwestern Medical Center
CompletedCandesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH
NCT00607633
AstraZeneca
CompletedEffect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hy
NCT01425411
Mustafa Kemal UniversityPhase 4
UnknownChronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)
NCT00418041
Hiroaki Shimokawa, MD, PhD
CompletedAttenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan
NCT00602004
Melbourne HealthN/A
CompletedCandesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)
NCT00348686
AstraZenecaPhase 4
UnknownStenting of Renal Artery Stenosis in Coronary Artery Disease Study
NCT01173666
Azienda Ospedaliera, Universitaria Policlinico Vittorio EmanuelePhase 3
UnknownEffect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Re
NCT00294775
Odense University HospitalPhase 3
CompletedAliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy
NCT00219141
Novartis PharmaceuticalsPhase 3
TerminatedHypertension in Hemodialysis Patients (Aim 3)
NCT00582114
Indiana UniversityPhase 3
CompletedValue of Cardiac Magnetic Resonance (CMR) Derived Parameters for Diagnosing Left Ventricular Non-compaction Ca
NCT01481298
University of Leipzig
CompletedEffects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertens
NCT00139555
NovartisPhase 4
CompletedPulse Wave Analysis and Velocity in Patients With Chronic Renal Failure: a Cross-sectional Observational Study
NCT01579032
Universitaire Ziekenhuizen KU Leuven
CompletedPathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
NCT00518479
University of LeedsN/A
CompletedHypertension in Hemodialysis
NCT00067665
Indiana UniversityN/A
CompletedAccess Creation for Hemodialysis: Association With Structural Changes of the Heart
NCT00368147
Ottawa Hospital Research Institute
TerminatedActive Vitamin D Effect on Left Ventricular Hypertrophy
NCT00175149
Per IvarsenPhase 4
CompletedFactors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts
NCT00001878
National Heart, Lung, and Blood Institute (NHLBI)
CompletedA Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.
NCT00364260
Janssen-Ortho Inc., CanadaPhase 3
CompletedInvestigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease
NCT00001632
National Heart, Lung, and Blood Institute (NHLBI)
CompletedLong Term Effects of Enalapril and Losartan on Genetic Heart Disease
NCT00001534
National Heart, Lung, and Blood Institute (NHLBI)
CompletedStress Reduction in the Prevention of Left Ventricular Hypertrophy
NCT05373732
Maharishi International UniversityN/A